🇺🇸 FDA
Patent

US 9155778

Tripeptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SgIt1

granted A61KA61K38/06A61K38/08

Quick answer

US patent 9155778 (Tripeptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SgIt1) held by Julius-Maximilians-Universitat Wurzburg expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Julius-Maximilians-Universitat Wurzburg
Grant date
Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/06, A61K38/08, A61P, A61P3/00